---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-028007"
form_type: "8-K"
ticker: "BCAB"
cik: "0001826892"
company_name: "BioAtla, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:30:56.889735+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BioAtla stockholders elect three Class III directors at June 14, 2023 annual meeting

## Summary
- All three director nominees (Short, Smith, Williams) elected with ~79% votes for excluding broker non-votes.
- Ratification of Ernst & Young as auditor for FY2023 passed with over 36.5M votes for.
- Non-binding advisory vote on executive compensation approved with ~27.5M for, ~1.4M against.
- 78.31% of outstanding shares represented at the meeting.

## SEC filing metadata
- accession: 0000950170-23-028007
- form_type: 8-K
- ticker: BCAB
- cik: 0001826892
- company_name: BioAtla, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/0000950170-23-028007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/bcab-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-028007
- JSON: https://secwatch.observer/filing/0000950170-23-028007.json
- Plain text: https://secwatch.observer/filing/0000950170-23-028007.txt

## Key facts
- Shareholder Votes
  BioAtla, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 by the following votes:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/0000950170-23-028007-index.htm
- Shareholder Votes
  BioAtla, Inc. shareholders approved Non-binding advisory vote on executive compensation of named executive officers at the 2023-06-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The Company’s stockholders approved, on a non-binding advisory basis, the executive compensation of our named executive officers by the following votes:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/0000950170-23-028007-index.htm
- Shareholder Votes
  BioAtla, Inc. shareholders approved Election of three Class III directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: The Company’s stockholders approved the election of three Class III directors to the Company’s Board of Directors for three year terms or until their respective successors are duly elected and qualified or until their earlier death, resignation, disqualification or removal, by the following votes:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/0000950170-23-028007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.